Insulet had seven patents in internet of things during Q2 2024. Insulet Corp’s patents in Q2 2024 focus on innovative techniques for controlling wearable drug delivery devices using voice commands, adapting insulin dosages based on delivery history, calculating insulin-on-board amounts, terminating electric pulses to medicament pumps based on resistance values, and adjusting basal insulin dosages based on blood glucose data and user preferences to prevent hypoglycemic or hyperglycemic events. GlobalData’s report on Insulet gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Insulet had no grants in internet of things as a theme in Q2 2024.
Recent Patents
Application: Audio/tactile input-output and audio control for automated insulin delivery applications (Patent ID: US20240197985A1)
The patent filed by Insulet Corp. describes a wearable drug delivery device equipped with sound chip circuitry and a voice control application to control the device's operation. The sound chip circuitry can play audio clips for user assistance, encouragement, and pediatric users. Users can control liquid drug delivery hands-free using voice commands and confirmations. The device can identify specific audio clips based on factors like time of day, location of the controller, and battery status, and can even record and store user-generated audio clips.
Furthermore, the wearable drug delivery device can receive voice commands for insulin delivery actions, confirm these commands, and execute the actions through an automated insulin delivery application. The sound chip circuitry can switch between listening modes based on activation keywords, recognize discrete amounts of insulin to be delivered, and utilize a natural language understanding module for interpreting voice commands. Additionally, the device can generate treatment program recommendations based on user verbal annotations categorized by the natural language understanding module. Overall, the patent outlines innovative features for enhancing user interaction, control, and customization of drug delivery systems through voice control and sound chip technology.
To know more about GlobalData’s detailed insights on Insulet, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
